Skip to main content
. 2016 Jul 26;6:26. doi: 10.1186/s13395-016-0098-2

Fig. 7.

Fig. 7

Effects of everolimus and CDD866 on muscle weight. Tibialis (a), gastrocnemius complex (b), and quadriceps (c). Values are expressed as means ± SEM (n = 10). Percent changes of muscle weight, normalized to initial body weight, were calculated in comparison to non-tumor control. ** P < 0.01 versus non-tumor control; ++ P < 0.01 versus Non-tumor everolimus; && P < 0.01 versus CT-26 control; # P < 0.05 versus CT-26 everolimus